Patient History
A 37 year-old male presented with a 3-4 month history of a painful skin lesion on the left plantar medial heel. The patient was evaluated and diagnosed with a verruca (plantar wart).
First Treatment
Second Treatment
Third Treatment
Fourth Treatment
Treatment
Initial treatment involved debridement and application of a topical acid. Mild improvement was noted over a six week treatment period. The patient continued to have pain with weightbearing and opted for Swift® treatment.
Results
The patient was treated monthly for four months along with local debridement of hyperkeratosis overlying the wart. During the treatment course, continued improvement was noted with near complete resolution of the wart, along with pain by the fourth treatment.
About Swift® Wart Treatment
Swift® is the pioneering new microwave therapy device for skin. Unlike other destructive treatment methods, this procedure targets the root cause of the wart/verruca – the human papillomavirus (HPV). Microwave energy is introduced into the skin, heating cells to between 36 and 43 degrees Celsius. This heat initiates an immune cascade which allows the body to detect and attack the HPV virus, ridding the patient of this painful condition. Treatment protocol includes an average of 3-4 visits with each treatment lasting only 5-10 minutes. Visits are spaced 4 weeks apart to coincide with the body’s immune cycle, with follow up scheduled for 12 weeks following the final treatment.
Jason M. Levy DPM, FACFAS
Dr. Jason M. Levy was the chief of podiatric surgery at Morton Plant / Mease Hospitals. Dr. Levy is Board Certified by the American Board of Foot and Ankle Surgery in Reconstructive Rearfoot/Ankle Surgery. He received his undergraduate degree in Biology at Oglethorpe University in Atlanta, Georgia, and his medical training from the Ohio College of Podiatric Medicine in Cleveland, Ohio. Dr. Levy was Chief Resident at JFK Medical Center in Atlantis, Florida where he completed three years of training in reconstructive foot and ankle surgery.
